$175B
$4.49 Billion
0.49% of portfolio
11,712
Q4 2024
Reduced 11.5%
$164B
$4.46 Billion
0.49% of portfolio
8,769
Q4 2024
Reduced 11.5%
$25B
$4.41 Billion
0.48% of portfolio
64,167
Q4 2024
Reduced 11.49%
$37.1B
$4.42 Billion
0.48% of portfolio
44,562
Q4 2024
Added 30.98%
$40.1B
$4.34 Billion
0.47% of portfolio
35,043
Q4 2024
Reduced 11.5%
$36.5B
$4.31 Billion
0.47% of portfolio
17,761
Q4 2024
Reduced 11.5%
$47.9B
$4.22 Billion
0.46% of portfolio
18,067
Q1 2025
Added 117.23%
$89.9B
$4.15 Billion
0.45% of portfolio
9,534
Q4 2024
Reduced 11.5%
$145B
$4.14 Billion
0.45% of portfolio
41,029
Q4 2024
Reduced 11.5%
$142B
$4.14 Billion
0.45% of portfolio
11,116
Q4 2024
Reduced 11.5%
$79.5B
$4.06 Billion
0.44% of portfolio
18,387
Q4 2024
Reduced 8.07%
$177B
$4.01 Billion
0.44% of portfolio
22,314
Q1 2025
New
$143B
$3.91 Billion
0.43% of portfolio
19,091
Q4 2024
Reduced 11.5%
$11.4B
$3.79 Billion
0.41% of portfolio
15,306
Q4 2024
Reduced 11.5%
$27B
$3.65 Billion
0.4% of portfolio
93,062
Q4 2024
Reduced 11.49%
$45.6B
$3.58 Billion
0.39% of portfolio
49,330
Q4 2024
Reduced 11.49%
$104B
$3.57 Billion
0.39% of portfolio
5,309
Q4 2024
Reduced 11.52%
$170B
$3.62 Billion
0.39% of portfolio
23,546
Q4 2024
Reduced 11.5%
$117B
$3.5 Billion
0.38% of portfolio
17,342
Q1 2025
New
$69.4B
$3.46 Billion
0.38% of portfolio
907
Q4 2024
Reduced 11.68%
$67.4B
$3.37 Billion
0.37% of portfolio
114,631
Q4 2024
Reduced 11.49%
$73.2B
$3.38 Billion
0.37% of portfolio
36,119
Q4 2024
Reduced 11.49%
$16.1B
$3.35 Billion
0.37% of portfolio
54,312
Q1 2025
Added 143.42%
$30.9B
$3.33 Billion
0.36% of portfolio
48,703
Q4 2024
New
$39.1B
$3.19 Billion
0.35% of portfolio
41,646
Q4 2024
Reduced 11.49%
$53.7B
$3.22 Billion
0.35% of portfolio
20,870
Q4 2024
Reduced 11.5%
$11.8B
$3.25 Billion
0.35% of portfolio
19,885
Q4 2024
Reduced 8.06%
$99.6B
$3.18 Billion
0.35% of portfolio
18,419
Q4 2024
Reduced 11.5%
$12.3B
$3.08 Billion
0.34% of portfolio
21,549
Q4 2024
Reduced 11.5%
$146B
$3.12 Billion
0.34% of portfolio
21,473
Q4 2024
Reduced 48.37%
$30.3B
$3.07 Billion
0.34% of portfolio
11,618
Q4 2024
New
$215B
$2.88 Billion
0.31% of portfolio
4,689
Q1 2025
Reduced 51.6%
$48B
$2.86 Billion
0.31% of portfolio
9,607
Q4 2024
Reduced 11.51%
$157B
$2.88 Billion
0.31% of portfolio
6,136
Q4 2024
Reduced 11.51%
$54.5B
$2.84 Billion
0.31% of portfolio
5,875
Q4 2024
Reduced 11.51%
Regeneron Pharmaceuticals
-
$2.82 Billion
0.31% of portfolio
-
Q4 2024
Reduced 11.52%
$11.9B
$2.76 Billion
0.3% of portfolio
27,292
Q4 2024
Reduced 11.5%
$16.4B
$2.7 Billion
0.3% of portfolio
32,594
Q4 2024
Reduced 11.5%
$149B
$2.78 Billion
0.3% of portfolio
13,111
Q4 2024
Reduced 11.5%
$95.9B
$2.76 Billion
0.3% of portfolio
8,381
Q4 2024
Reduced 11.51%
$39.2B
$2.76 Billion
0.3% of portfolio
26,788
Q4 2024
Reduced 11.5%
$2.7B
$2.76 Billion
0.3% of portfolio
24,693
Q4 2024
Reduced 11.49%
$84.4B
$2.63 Billion
0.29% of portfolio
11,027
Q4 2024
Reduced 11.51%
-
$2.63 Billion
0.29% of portfolio
-
Q4 2024
Reduced 11.51%
$37.2B
$2.64 Billion
0.29% of portfolio
11,791
Q4 2024
Reduced 11.5%
$392B
$2.63 Billion
0.29% of portfolio
32,777
Q4 2024
Reduced 11.5%
$25.5B
$2.65 Billion
0.29% of portfolio
24,271
Q4 2024
Reduced 11.5%
$68.5B
$2.59 Billion
0.28% of portfolio
54,980
Q4 2024
Reduced 11.49%
-
$2.54 Billion
0.28% of portfolio
-
Q4 2024
Reduced 11.5%
$14.8B
$2.56 Billion
0.28% of portfolio
10,750
Q4 2024
New